Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -22711.52% is 98% below its 2-year average of -11491.99%, around the middle of its 2-year range (-32634.62%–-2520.47%).
111.93% below its 12-month average of -10716.48%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2024 (2024-12-31): -6152.55%.
EBITDA MARGIN
-22711.52%
EBITDA MARGIN AVG TTM
-10716.48%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-111.93%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Adagio Medical Holdings, Inc.
Market Cap
$3.07M
EBITDA Margin
-22711.52%
TTM Avg
-10716.48%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.04M
EBITDA Margin
-4291.67%
TTM Avg
-3563.06%
3Y Avg
-8274.29%
5Y Avg
-15578.54%
Market Cap
$3.37M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.34M
EBITDA Margin
-2030.10%
TTM Avg
-2765.29%
3Y Avg
-1907.45%
5Y Avg
-2238.98%
Market Cap
$3.47M
EBITDA Margin
-437.97%
TTM Avg
-452.41%
3Y Avg
-479.95%
5Y Avg
-376.71%
Market Cap
$3.48M
EBITDA Margin
-334.54%
TTM Avg
-323.48%
3Y Avg
-700.81%
5Y Avg
-1335.84%
Market Cap
$2.64M
EBITDA Margin
-375.69%
TTM Avg
-244.00%
3Y Avg
-166.51%
5Y Avg
-121.60%
Market Cap
$2.75M
EBITDA Margin
-163.38%
TTM Avg
-126.27%
3Y Avg
-20964.27%
5Y Avg
-20964.27%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.07M | -22711.52% | -10716.48% | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -4291.67% | -3563.06% | -8274.29% | -15578.54% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.34M | -2030.10% | -2765.29% | -1907.45% | -2238.98% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -437.97% | -452.41% | -479.95% | -376.71% |
| Evogene Ltd. (EVGN)vs › | $3.48M | -334.54% | -323.48% | -700.81% | -1335.84% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -375.69% | -244.00% | -166.51% | -121.60% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.75M | -163.38% | -126.27% | -20964.27% | -20964.27% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-22711.5%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-12-31 | -6152.55% |
| 2024-09-30 | -5608.11% |
| 2024-06-30 | -2520.47% |
| 2024-03-31 | -32634.62% |
| 2023-12-31 | -6666.67% |
| 2023-09-30 | -21904.88% |
| 2023-06-30 | -5565.29% |
| 2023-03-31 | -10883.33% |
